• Aucun résultat trouvé

Exploitant Declaration for France

N/A
N/A
Protected

Academic year: 2022

Partager "Exploitant Declaration for France "

Copied!
1
0
0

Texte intégral

(1)

""-"'

Horus

P H A A

m

A

Exploitant Declaration for France

Active substance: Travoprost

I

Timolol DC procedure number: DK/H/2636/001/DC

Product: Travoprost/Timolol 40 micrograms/ml+S mg/ml eye drops, solution

FR: TRAVOPROST/TIMOLOL HORUS PHARMA 40 microgrammes/ml + 5 mg/ml, collyre en solution

We hereby confirm that Exploitant will be declared to the ANSM before marketing of the product.

Kind regards,

Mrs. Carole Gard

R&D and RA Executive Director

SAS

au capital de 1 388 660 € Siret: 445 317 043 00013

APE: 7219Z • RCS ANTIBES 20038141 W TVA: FR17445317043

148, avenue G. Guynemer Cap Var 02

06700 Saint-Laurent du Var France

Tel.: 04 93 19 54 03 Fax : 04 93 19 54 09

E-mail: contact!ahorus-pharma.fr Site: www.horus-pharma.fr

Références

Documents relatifs